Besides nuclear events mediated by intracellular ER binding, many of these compounds also exert non-genomic effects through the activation of the membrane-associated ERs (mERs) and/or G-protein-coupled estrogen receptor 1 (GPER1/GPR30), which are involved in a diverse array of disorders, including cancer [61,62,63]. Here, ESR1 is linked to cancer.